POLYTECH MESMO和Motiva Ergonomix乳房植入物在移位问题上的比较：一位外科医生对329例患者的经验。

Comparison of POLYTECH MESMO and Motiva Ergonomix Breast Implants With Focus on Displacement Issues: A Single Surgeon's Experience with 329 Patients.

作者信息

Montemurro Paolo

出版信息

Aesthet Surg J. 2024 Aug 20;44(9):948-956. doi: 10.1093/asj/sjae071.

DOI:10.1093/asj/sjae071

PMID:38547508

Abstract

BACKGROUND

Nanotextured breast implants (classified as smooth implants by the latest ISO 14607:2018) have been described as possibly reducing major textured implant-related complications such as capsular contracture and breast implant-associated anaplastic large cell lymphoma. On the other hand, microtextured breast implants benefit from an optimal safety profile based on a much larger body of literature.

OBJECTIVES

The aim of this study was to directly compare the incidence of complications between Motiva Ergonomix (Establishment Labs Holdings, Inc., Alajuela, Costa Rica) and POLYTECH MESMO (POLYTECH Health & Aesthetics GmbH, Dieburg, Germany) breast implants, especially regarding the displacement issues that might arise after breast augmentation.

METHODS

Consecutive patients who previously underwent surgery by the same physician for placement of Motiva Ergonomix and POLYTECH MESMO implants were included in this study. They were divided into 2 groups according to the type of implant. The onset of complications was assessed through survival analysis.

RESULTS

Data were collected from 329 patients, 185 (56.2%) with POLYTECH MESMO and 144 (43.8%) with Motiva Ergonomix implants. The median follow-up was 8 months for both groups. Of the 42 women (12.8%) who experienced at least one complication, 26 belonged to the Motiva Ergonomix subgroup (P = .013). The most represented complications during this period resulted from displacement issues, with a clear prevalence of bottoming out in the Motiva Ergonomix cohort: 15 cases vs 0 cases in the POLYTECH MESMO cohort (P < .001). For 7 patients, a reoperation was required, more frequently for patients with Motiva Ergonomix implants (4.2% vs 0.5%; P = .046).

CONCLUSIONS

POLYTECH MESMO devices provided a more favorable outcome. Motiva Ergonomix devices revealed a concerning incidence of displacement issues during the first postsurgery years, with no advantage over other major complications.

摘要

背景

纳米纹理乳房植入物（根据最新的ISO 14607:2018分类为光滑植入物）被认为可能会减少与纹理植入物相关的主要并发症，如包膜挛缩和乳房植入物相关的间变性大细胞淋巴瘤。另一方面，基于更多的文献资料，微纹理乳房植入物具有最佳的安全性。

目的

本研究的目的是直接比较Motiva Ergonomix（Establishment Labs Holdings, Inc., 阿拉胡埃拉，哥斯达黎加）和POLYTECH MESMO（POLYTECH Health & Aesthetics GmbH, 迪堡，德国）乳房植入物的并发症发生率，特别是关于隆乳术后可能出现的移位问题。

方法

本研究纳入了由同一位医生先前进行Motiva Ergonomix和POLYTECH MESMO植入物手术的连续患者。根据植入物类型将他们分为两组。通过生存分析评估并发症的发生情况。

结果

收集了329例患者的数据，其中185例（56.2%）植入了POLYTECH MESMO，144例（43.8%）植入了Motiva Ergonomix。两组的中位随访时间均为8个月。在经历至少一种并发症的42名女性（12.8%）中，26名属于Motiva Ergonomix亚组（P = 0.013）。在此期间最常见的并发症是移位问题，Motiva Ergonomix队列中明显以乳房下极下垂为主：15例，而POLYTECH MESMO队列中为0例（P < 0.001）。7名患者需要再次手术，Motiva Ergonomix植入物患者更频繁（4.2%对0.5%；P = 0.046）。